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SUMMARY
Introduction/Objective The aim of this study was to determine clinical and radiographic periapical 
healing of teeth with apical periodontitis treated with different formulations of calcium hydroxide (CH) 
– paste (CH-paste) and gutta-percha points (CH-GP) – as well as those of chlorhexidine (CHX) – gel (CHX-
gel) and gutta-percha points (CHX-GP) –12 months after therapy. 
Methods Eighty patients with chronic apical periodontitis were randomly allocated to four treatment 
groups according to the intracanal medicament used: CH-paste, CH-GP, CHX-gel, and CHX-GP group. 
Seventy-eight patients were analyzed clinically and radiographically 12 months postoperatively. The 
periapical index (PAI) was used for the radiographic evaluation of treatment. 
Results Overall outcome was classified according to radiographic evaluation only, since clinical success was 
observed in all the patients. In all the groups, significant reduction in PAI scores was observed (p < 0.001). 
The proportions of healed teeth (PAI ≤ 2) were 73.7%, 60%, 68.4%, and 65% in CH-paste, CH-GP, CHX-gel 
and CHX-GP group, respectively, with no significant differences between the groups. 
Conclusion The results suggest that there are no differences between investigated CH- and CHX-delivery 
systems regarding treatment outcome of teeth with apical periodontitis.
Keywords: calcium hydroxide; chlorhexidine; periapical diseases; root canal therapy; treatment outcome
INTRODUCTION
Microorganisms play a key role in the devel-
opment and persistence of apical periodontitis 
and the success of endodontic therapy depends 
on their reduction. Mechanical instrumenta-
tion and irrigation significantly reduce but do 
not completely eliminate microbiota present 
in the root canal [1]. Therefore, the use of an 
interappointment intracanal dressing has been 
recommended to supplement the antibacterial 
effects of chemomechanical procedures and 
maximize bacterial reduction [2].
Calcium hydroxide (CH) is one of the most 
effective antibacterial dressings during endo-
dontic therapy due to its antimicrobial activ-
ity, tissue-dissolving ability, detoxification of 
lipopolysaccharides, and induction of repair by 
formation of hard tissue [3]. Despite the favora-
ble properties of CH, other substances, such as 
chlorhexidine (CHX), have been proposed with 
the aim of targeting bacteria resistant to CH [4].
Effectiveness of intracanal medicament de-
pends not only on its antibacterial effect but 
also on its bioavailability directly influenced by 
the delivery system. CH is commonly mixed 
with aqueous, viscous, or oily vehicles, while 
CHX has been used in the form of liquid or gel. 
Another delivery method for intracanal dress-
ing is the use of gutta-percha points impregnat-
ed with medicament, either CH or CHX. Ac-
cording to the manufacturer, these points are 
easy to insert and remove from the canal, and 
they have the ability to release large quantities 
of medicament from their surface in a time-
dependent fashion. To date, almost all research 
about medicated gutta-percha points consid-
ered only their in vitro antibacterial activity, 
with contrasting results [5–11]. More recently, 
antibacterial effects of medicated gutta-percha 
points were evaluated in clinical settings [12, 
13]. Investigations found no difference be-
tween CH gutta-percha points (CH-GP) and 
CH paste [12, 13] or CHX gutta-percha points 
(CHX-GP) [13]. Regardless of the reported an-
tibacterial efficacy of medicated gutta-percha 
points from some in vitro and in vivo stud-
ies, clinical decision making should be based 
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on the outcome of clinical research, because antibacterial 
efficacy and successful therapeutic treatment might not 
always coincide with each other [5–13]. Long-term effec-
tiveness of CH-GP as intracanal medicament was inves-
tigated in just a few studies, mainly case reports. CH-GP 
were showed to be successful in the treatment of different 
types of periapical lesions [14], root resorption [14, 15], 
and for apexification treatment [16]. 
Thus, the aim of this study was to determine the 
12-month clinical and radiographic periapical healing of 
teeth with apical periodontitis treated with different for-
mulations of CH (paste and gutta-percha points) and CHX 
(gel and gutta-percha points). The null hypothesis tested 
was that the type of intracanal medicament (CH vs. CHX) 
or its formulation (paste and gel vs. gutta-percha points) 
had no influence on the clinical and radiographic healing 
of teeth with apical periodontitis.
METHODS
Patient selection
The study was approved by the Ethics Committee of the 
Faculty of Medicine and conformed to the principles 
embodied in the Declaration of Helsinki. A sample was 
selected from patients referred to the Endodontic Depart-
ment of the Faculty for nonsurgical root canal treatment 
between 2011 and 2013. 
The inclusion criteria for the study were as follows: 1) 
healthy subjects age 18 years and older, both sexes; 2) single-
rooted and single-canalled teeth with nonvital pulps, con-
firmed by negative response to sensitivity pulp test (cold 
and electric stimulation tester); 3) the presence of periapical 
radiolucencies (minimum size ≥ 2 × 2 mm); 4) no previous 
endodontic therapy of the involved tooth; 5) the absence of 
tooth or root fracture of the involved tooth; 6) the absence 
of periodontal pocket (> 4 mm) of the involved tooth.
The exclusion criteria were the following: 1) the absence 
of enough tooth structure for rubber dam isolation; 2) pa-
tients with contributory medical history; 3) patients who 
received antibiotic therapy during previous six months.
Once eligibility was confirmed and after written and 
verbal informed consent was obtained, the patient was 
randomly assigned to one of the following four groups 
according to the intracanal medicament used: CH-paste 
(Calxyl-blue, OCO Products GMBH, Dirnstein, Ger-
many), CH-GP (Roeko Calcium hydroxide Plus Points, 
Coltene/Whaledent, Langenau, Germany), CHX-gel (Con-
sepsis V, Ultradent, South Jordan, UT, USA), and CHX-GP 
(Roeko Active Points, Coltene/Whaledent, Langenau, Ger-
many). The sample was randomized using computer-gen-
erated random numbers, by a person who did not belong 
to the research group. The group assignment was passed 
on to the clinician, endodontic specialist, only at the time 
of treatment. Operator blinding could not be performed 
due to different colors and forms of used medicaments. 
The minimum sample size per group was determined 
with the method described by Zhong [17]. Sixteen teeth 
per group were calculated to be required to obtain a power 
of 80% at the 5% level of significance, with minimal clini-
cally significant mean difference between groups of 0.5 
units (standard deviation ± 0.5 unit) using the periapical 
index (PAI) scale [18]. Assuming possible losses of 20% 
during the 12-month follow-up period, the number of 
teeth per group was adjusted to 20.
Clinical procedures
Each tooth was polished with pumice and isolated from 
the oral cavity with a rubber dam. Antisepsis of the crown 
and operative field was conducted according to a previ-
ously described decontamination protocol [19]. All sub-
sequent procedures were performed aseptically. Caries 
lesion and/or leakage restoration were removed and a 
standard access cavity was prepared. The canal working 
length was established using the apex locator (Raypex® 5, 
VDW, GmbH, Munich, Germany) and confirmed radio-
graphically. Canal instrumentation was performed using 
the step-back technique with K-type files (0.02 taper ISO) 
and Gates–Glidden drills (both from Dentsply/Maillefer, 
Ballaigues, Switzerland) to the apical size of at least #35 
depending on both the initial size of the root canal and 
root anatomy. Canal was irrigated with 2 mL of 1% sodium 
hypochlorite after each file size. When instrumentation 
was completed, the canal was flushed with 5 mL of 17% 
ethylenediaminetetraacetic acid followed by 5 mL of 1% 
sodium hypochlorite. After drying the canal with sterile 
paper points, intracanal medicament was placed in the 
root canal. For teeth assigned to the CH-paste group, a 
lentulo spiral was used to fill the canal with the paste. In 
the CHX-gel group, the gel was placed into the root canals 
by means of a syringe and needle. Teeth in the CH-GP and 
CHX-GP groups were dressed by using medicated gutta-
percha point inserted to full working length into the canal 
with a drop of sterile water, according to the manufac-
turer’s instructions. The access cavity was sealed with tem-
porary filling (Cavit, 3M ESPE AG, Seefeld, Germany) and 
glass ionomer cement (Fuji IX, GC, Tokyo, Japan). After 15 
days with intracanal medication, root canal was obturated 
with gutta-percha and AH Plus sealer (Dentsply, DeTrey, 
GmbH, Konstanz, Germany) using cold lateral compac-
tion technique. Definitive restoration was obtained within 
one month after the completion of treatment. 
Assessment of treatment outcome
The comparisons of clinical and radiographic findings at 
the 12-month follow-up with that documented at preop-
erative examination were used for the assessment of out-
come of endodontic therapy. One investigator, uninvolved 
in the treatment of the subjects, performed all follow-up 
examinations. 
Clinical outcome measures were the evaluation of the 
presence of pain, percussion, and palpation sensitivity, 
soft tissue status, tooth mobility, marginal bone level at 
12 months. Absence of spontaneous pain and percussion 
or palpation sensitivity, absence of sinus tract, absence 
Stojanović N. et al.
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of soft-tissue swelling, absence of tooth mobility and no 
increase in periodontal probing depth compared with 
baseline values were used as clinical criteria for treatment 
success (healing).
Radiographic outcome measure was the change in 
periapical radiolucencies at the 12-month follow-up. The 
radiograph at the follow-up was made by using the indi-
vidual patient’s bite registration and the same exposure set-
tings used for the preoperative image. PAI score was used 
for radiographic evaluation of treatment success [18]. The 
index consists of five categories numbered 1–5 as follows: 
1 – normal periapical structures; 2 – small changes in bone 
structure; 3 – changes in bone structure with some mineral 
loss; 4 – periodontitis with well-defined radiolucent area; 
5 – severe periodontitis with exacerbating features; scores 
of 3 or higher represent disease.
All radiographic films obtained preoperatively and at 
follow-up were coded blind and organized in a random or-
der. To improve calibration and inter-examiner agreement, 
two experienced endodontists who had not been involved 
in the treatment or the follow-up appointments analyzed 
a series of radiographs (not related to the study samples) 
representing a wide range of periapical bone densities, be-
fore study evaluation. After this, they independently ana-
lyzed the study radiographs under moderate illumination 
at a light table. In cases of disagreement, joint re-evalua-
tion was performed and consensuses were achieved. After 
one month, the examiners repeated the entire analysis of 
study radiographs. Inter- and intra-examiner agreement 
produced a Cohen kappa above 0.71 and 0.81, respectively.
At 12-month follow-up, a tooth was classified as healed 
if it presented no clinical signs or symptoms and had 
PAI ≤ 2, or as unhealed if clinical signs or symptoms were 
presented and/or had PAI ≥ 3.
Statistical analysis
SPSS 19.0 for Windows (IBM Corp., Armonk, NY, USA) 
was used for statistical analysis. The distribution of the 
variables: sex, dental arch involved and tooth type was 
evaluated using the χ2 test, while age was analyzed using 
ANOVA. The Kruskal–Wallis followed by Mann–Whit-
ney U-test and Wilcoxon signed rank test were used for 
intergroup and intragroup comparison of PAI scores, at 
baseline and at the 12-month follow-up, respectively. To 
determine the difference in proportion of healed teeth be-
tween the groups and to identify variables that may influ-
ence the treatment outcome, the χ2 was used. The level of 
p < 0.05 was chosen for statistical significance.
RESULTS
Demographic data
At the start of the treatment, 80 healthy persons (29 males) 
were recruited. The mean age was 37.58 (range 18–76) 
years. From each patient, only one tooth was included; 
20 teeth per each group. Two of the 80 teeth included in 
the study were lost at the 12-month follow-up (one in the 
CH-paste and one in the CHX-gel group).
Comparisons between the groups showed no statistical 
difference in the distribution of age, sex, tooth type, or 
dental arch involved (Table 1).
Treatment outcome
At 12-months examination none of the patients had any 
clinical symptoms and/or abnormal findings. The PAI 
scores at baseline and at the 12-month follow-up for CH-
paste, CH-GP, CHX-gel and CHX-GP are presented in Ta-
ble 2. No significant differences between the groups were 
observed for both baseline examination and the 12-month 
control. Intragroup analysis revealed that in all treatment 
protocols PAI score decreased significantly (p < 0.001). An 
improvement in the PAI score was found in all patients 
except for three cases (15%) in the CH-GP group. Success-
ful healing (PAI ≤ 2) was observed in 73.7%, 60%, 68.4%, 
and 65% of cases in groups CH-paste, CH-GP, CHX-gel 
and CHX-GP, respectively (p = 0.832). 
Influence of other selected variables on treatment out-
come in the total material is presented in Table 3. The 
only factor that showed a positive favorable influence on 
radiographic healing was the existence of a preoperative 
periapical lesion smaller than 5 mm (p = 0.001). 




















CH-paste 19 39.58 ± 10.96 7 (36.8) 12 (63.2) 9 (47.4) 4 (21) 6 (31.6) 12 (63.2) 7 (36.8)
CH-GP 20 37.55 ± 17.86 5 (25) 15 (75) 13 (65) 2 (10) 5 (25) 10 (50) 10 (50)
CHX-gel 19 39.53 ± 17.32 6 (31.6) 13 (68.4) 10 (52.6) 3 (15.8) 6 (31.6) 14 (73.7) 5 (26.3)
CHX-GP 20 34.65 ± 11.12 9 (45) 11 (55) 9 (45) 2 (10) 9 (45) 14 (70) 6 (30)
Total 78 37.78 ± 14.56 27 (34.6) 51 (65.4) 41 (52.6) 11 (14.1) 26 (33.3) 50 (64.1) 28 (35.9)
p 0.692 0.596 0.765 0.424
CH-paste – calcium hydroxide paste; CH-GP – calcium hydroxide gutta-percha points; CHX-gel – chlorhexidine gel; CHX-GP – chlorhexidine gutta-percha points 
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DISCUSSION
In this study, clinical and radiographic parameters of apical 
periodontitis healing were evaluated concerning different 
form of intracanal medicaments, paste and gutta-percha 
points for CH, and gel and gutta-percha points for CHX. 
To the best of our knowledge, this is the first clinical study 
assessing the effect of these points on periapical healing. 
All types of medicaments resulted in similar periapical 
healing patterns.
In the present study, the patients were randomly assigned 
to treatment groups and no significant difference was found 
between them in terms of preoperative factors (age, sex, 
tooth type, dental arch, and PAI score at baseline). Root 
canal treatment was performed according to a standard-
ized protocol by one experienced endodontist, representing 
specialty practice settings. Since clinical success of treat-
ment was observed in all the patients, overall outcome was 
classified according to radiographic evaluation. Limited 
diagnostic ability of periapical radiography has been well 
reported on. It has been shown that cone-beam computed 
tomographic imaging is more accurate than radiography for 
identifying periapical lesions. However, periapical radiogra-
phy has been used in almost all endodontic outcome studies 
so far and has been adopted as a standard of practice. In 
addition, cone-beam computed tomographic is not recom-
mended for routine diagnosis of periapical pathosis and the 
assessment of the root canal treatment outcome [20]. The 
applied criteria for treatment outcome were based on those 
suggested by Ørstavik et al. [18] accepted as a valid and reli-
able tool for measuring radiographic changes in apical bone 
density. The variability in radiographic reading is well rec-
ognized due to subjectivity of radiographic assessment. To 
overcome this shortcoming radiographic evaluation in our 
study was performed by two examiners with a substantial 
level of intra- and inter-examiner agreement. One-year ob-
servation period for radiological outcome in this study was 
chosen as most of the teeth with preoperative apical peri-
odontitis heal during the first year after treatment [21, 22].
All treatment protocols led to significant decrease in 
PAI scores. About 73.7% of teeth could be judged as healed 
in the CH-paste group, 60% in the CH-GP, 68.4% in the 
CHX-gel, and 64% in the CHX-GP group. The healing rate 
observed in the CH-paste group corroborates the results of 
previous studies in which the calcium hydroxide has been 
used for intracanal medication of teeth with apical peri-
odontitis [21, 22, 23]. Concerning CHX, the only available 
clinical report showed a healing rate of 94% in two to four 
years of follow-up after treatment with 2% CHX in the form 
of liquid, a rate much higher than for CHX in our study [24]. 
Disagreement with our findings may be due to difference 
in chemomechanical preparation, delivery system used for 
medication, and the time frame for outcome observation. 
However, if a decrease in PAI score was used as a favorable 
outcome, the number of healed teeth in our study would 
concur well with that obtained by the mentioned study [24].
Calcium hydroxide was used as a dressing material in 
most studies dealing with treatment outcome, with very 
few exceptions [23]. There are only a few studies which 
demonstrated that the type of intracanal medicaments sig-
nificantly influence the outcome. The use of calcium hy-
droxide medicament resulted in better treatment outcome 
than no dressing or the one containing corticosteroids 
[20, 25]. In the present study, the outcome of endodontic 
therapy of teeth with apical periodontitis did not signifi-
cantly differ between the groups. Thus, from the clinical 
point of view, the healing pattern seems largely unrelated 
Table 2. Periapical status according to Periapical Index (PAI) before and after a 12-month follow-up for each group
PAI

















1 0 0 0 0 12 8 10 10 < 0.001
2 0 0 0 0 2 4 3 3 < 0.001
3 3 2 4 5 5 4 5 7 < 0.001
4 13 12 10 11 0 3 1 0 < 0.001
5 4 6 6 4 0 1 0 0 < 0.001
p 0.681 0.434
CH-paste – calcium hydroxide paste; CH-GP – calcium hydroxide gutta-percha points; CHX-gel – chlorhexidine gel; CHX-GP – chlorhexidine gutta-percha points
Tabl e 3. Bivariate association between selected variables and success 
rate (PAI ≤ 2) in total sample
Variables n Success (PAI ≤ 2) n (%) p
Age (years)
< 38 46 30 (65.2) 0.810
≥ 38 32 22 (68.8)
Sex
Female 51 33 (64.7) 0.801
Male 27 19 (70.4)
Tooth type
Anteriors 52 32 (61.5) 0.210
Premolars 26 20 (76.9)
Tooth location
Maxilla 50 30 (60) 0.134
Mandible 28 22 (78.6)
Size of lesion (mm)
< 5 62 47 (77) 0.001
≥ 5 26 14 (23)
Root-filling*
Acceptable 64 46 (71.9) 0.058
Unacceptable 14 6 (42.9)
n – number of teeth;
*Acceptable fi lling – the fi lling ends 0–2 mm short of the radiographic apex 
with no voids visible within the material or between the material and the root 
canal walls; unacceptable fi lling – the fi ling material ends more than 2 mm 
from the radiographic apex or extruded beyond the apex and/or visible voids 
within or between the material and the root canal walls
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to the type and delivery system of intracanal medicament 
used, suggesting that both CH- and CHX-based medi-
caments can be used in therapy of primary chronic api-
cal periodontitis. However, there was a tendency toward 
more favorable outcome in teeth medicated with CH-paste 
(75%) in comparison with CH-GP (60%). Considering the 
facts that both CH formulations placed in root canal for 
15 days showed similar efficacy in periapical healing, and 
that CH-GP contain more than two times as much CH 
than CH-paste (58% vs. 23%), it can be assumed that bio-
availability of CH in CH-GP is lower. Accordingly, release 
kinetics of calcium and hydroxyl ions from CH-GP was 
lower than that of other form of CH [12, 26, 27]. In addi-
tion, CH-GP presented short-term alkalinity and minor 
antimicrobial activity in comparison to CH-paste [9, 10, 
11, 28]. In contrast to CH, CHX by itself possess significant 
pharmacokinetics characteristics, adsorption on oral mu-
cosa and the microbial cell wall (antimicrobial substantiv-
ity), which enable its long-lasting antibacterial effect. Some 
authors found that CHX gel seemed to be more effective 
than CHX-GP in the reduction of bacterial counts in situ 
and in the inhibition of bacterial colonization of the dentin 
in vitro [5, 29]. Comparing mentioned in vitro and in situ 
findings considering only bacterial effectiveness with our 
results concerning outcomes obtained from clinical settings 
gel of 2% CHX and gutta-percha points of 5% CHX show-
ing similar rate of periapical healing, it could be suggested 
that in clinical settings there are no differences between 
investigated CHX delivery systems in their bioavailabil-
ity. Considering the influence of medicated gutta-percha 
points on periapical tissue healing, there is only data about 
CH-GP, mainly from clinical case series showing CH-GP to 
be very successful in treating teeth with persistent periapi-
cal inflammation [14]. Moreover, Bezgin et al. [16] found 
acceptable results in apexification treatment using CH-GP 
and recommended these points as an apexification agent in 
cases where CH apexification is indicated. However, direct 
comparison of the present study with studies mentioned 
above concerning healing outcome is difficult to make, due 
to differences in the study population, diagnosis, and the 
treatment protocol. Further studies, including larger sam-
ple sizes, are needed to elucidate clinical effectiveness of 
medicated gutta-percha points on periapical healing.
In this study we also analyzed possible influence of 
other variables on treatment outcome. For the total mate-
rial, only the size of the periapical lesion had significant 
impact. Teeth with a preoperative lesion greater than 5 
mm had lower healing rate than teeth with smaller lesions. 
Having in mind that the healing process is a function of 
time, a favorable outcome of a smaller-sized lesion should 
be applicable to a larger-sized lesion if sufficient time was 
allowed for healing to take place [30]. 
 
CONCLUSION
Under the conditions of this study, there are no differ-
ences between investigated CH- and CHX-delivery sys-
tems regarding treatment outcome of teeth with apical 
periodontitis. Definitive conclusions about the influence 
of the type of intracanal medicament on periapical healing 
cannot be drawn and further randomized controlled trials 
to identify the most appropriate medication regime (type 
and method) are needed.
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САЖЕТАК
Увод/Циљ Циљ овог истраживања је био да се испита кли-
нички и радиографски исход лечења зуба са апексним пе-
риодонтитисом 12 месеци после завршене терапије и при-
мене различитих облика калцијум-хидроксида (КХ): паста 
(КХ-паста) и гутаперка поени (КХ-ГП) и хлорхексидина (ХХ): 
гел (ХХ-гел) и гутаперка поени (ХХ-ГП).
Методе Рандомизовано je 80 испитаника са хроничним 
периапексним лезијама у четири групе на основу врсте 
коришћеног интерсеансног медикамента: КХ-паста, КХ-ГП, 
ХХ-гел и ХХ-ГП. Дванаест месеци после завршеног лечења 
прегледано је 78 испитаника и урађени су ретроалвеолар-
ни снимци. За процену радиографског успеха лечења ко-
ришћен је периапикални индекс (ПИ).
Резултати Исход лечења је класификован на основу ра-
диолошког налаза јер је код свих испитаника забележен 
клинички успех лечења. У свим испитиваним групама је 
забележено значајно смањење вредности ПИ (p < 0,001). 
Излечење (ПИ ≤ 2) уочено је код 73,3% зуба у групи КХ-пас-
та, 60% у КХ-ГП групи, 68,4% у групи ХХ-гел и код 65% зуба 
у групи ХХ-ГП, при чему разлике између група нису биле 
статистички значајне.  
Закључак Резултати овог истраживања показују да не 
постоји разлика у исходу лечења зуба са апексним пери-
одонтитисом после примене испитиваних облика КХ и ХХ.
Кључне речи: калцијум-хидроксид; хлорхексидин; пери-
апексно обољење; ендодонтски третман; исход лечења
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